Merck
CN
Search Within
文件类型

205-305-4

应用筛选条件
关键词:'205-305-4'
显示 1-28 共 28 条结果 关于 "205-305-4" 范围 技术文档
Data Sheet - H4042
410 (1996). 3. Le Roith, D. et al., Endocrine Rev., 22, 53-74 (2001). 4. Roskam, W. et al., Nucleic Acids Res., 7, 305-320 (1979). 5. Welniak, L.A. et al., J. Leukoc. Biol., 71, 381-387 (
Data Sheet - P3362
Yang, A., et al., Mol. Cell, 2, 305-316 (1998). 2. Chen, X., Mol. Med. Today, 5, 387-392 (1999). 3. Levrero, M., et al., Cell Death Differ., 6, 1146-1153 (1999). 4. Marin, M.C., and Kaelin, W.G., Biochim
Data Sheet - P3737
Yang, A., et al., Mol. Cell, 2, 305-316 (1998). 2. Yang, A., et al., Nature, 398, 714-718 (1999). 3. Signoretti, S., et al., Am. J. Pathol., 157, 1769- 1775 (2000). 4. Liefer, K.M., et al., Cancer Res
Data Sheet - P3735
protein. Cell, 88, 205-211 (1997). 3. Mayer, B.J., et al., Evidence that SH2 domains promote processive phosphorylation by protein- tyrosine kinases. Curr. Biol. 5, 296-305 (1995). 4. Guo, D., et al.
Data Sheet - T7068
sealed and protected from light at –20 °C. References 1. Nishizuka, Y., Science 233, 305-312. (1986). 2. Jaken, S., Current Opinion in Cell Biology, 8, 168-173 (1996).
TB029
3 706 940 3259 BglII 1 140 BpmI 4 603 1157 1773 3209 Bpu10I 1 1352 BsaI 2 107 3200 BsaAI 1 1998 BsaBI 3 139 145 1443 BsaHI 6 185 206 320 977 3676 4058 BsaJI 6 299 305 938 1140 1218 2406 BsaWI 5 464
XP725 Antibody Number-Lot Number 071M4826
346 347 348 369 370 371 372 4.4 301 302 303 304 325 326 327 328 349 350 351 352 373 374 375 376 4.5 305 306 307 308 329 330 331 332 353 354 355 356 377 378 379 380 4.64. 309
Product Information Sheet - SE120095
1996;105:205-9. 3. Shearman, M.J. et al., Mycoplasma pneumoniae infection: early diagnosis by detection of specific IgM by immunofluorescence. Br. J. Biomed. Sci., 1993;50:305-8. 4. Lee, S.H.
Product Information Sheet - SE120096
1996;105:205-9. 3. Shearman, M.J. et al., Mycoplasma pneumoniae infection: early diagnosis by detection of specific IgM by immunofluorescence. Br. J. Biomed. Sci., 1993;50:305-8. 4. Lee, S.H.
SF7761 Human DIPG H3.3-K27M N Cell Line
Res. 75(1-2): 205–209. 2. Lewis PW et al. (2013) Science 340(6134): 857–861. 3. Chan KM et al. (2013) Genes & Development 27(9): 985- 990. 4. Piunti A et al. (2017) Nat. Med. 23(4): 493-500.
Examination of Non-Specifically Bound Proteins and Peptides Following Depletion of Twenty High Abundance Proteins from Human Plasma
4 468 4 305 4 389 4 IPI00027737 Melanoma-derived leucine zipper-containing extranuclear factor 50 1 50 1 50 1 50 1 50 1 49 1 IPI00298971 Vitronectin precursor 51 1 112 2 99 2 IPI00329547 Zinc
Apoptosis - Antibodies, Reagents and Kits
Anti-DOK, C-terminus H WB Rb 100 µg AB16948 $205 DRAK Anti-DRAK1, N-terminus H M R WB Rb 100 µg AB16514 $205 Anti-DRAK2, C-terminus H WB Rb 100 µg AB16515 $205 Endonuclease G
Analyzing Fatty Acids by Capillary Gas Chromatography
Column: Omegawax 250, 30m x 0.25mm ID, 0.25µm film Cat. No.: 24136 Oven: 205°C Carrier: helium, 30cm/sec, set at 205°C Det.: FID, 260°C Inj.: 1µL of Omegawax Test Mix (25mg FAMEs/mL hexane)
An Update on Ligands for Prostanoid Receptors
Prost. Thromb. Leukot. Res., 11, 229-305 (1983). 72. Sturzebecher, S. et al., Prostaglandins, 31, 95-109 (1986). 73. Schneider, J., et al., Cardiovasc. Drug Rev., 4, 479-500 (1993). 74. Armstrong, R.A.
Article: Evaluation of immunological parameters in pit bull terrier-type dogs with juvenile onset generalized demodicosis and age-matched healthy pit bull terrier-type dogs
monocyte chemoattractant protein-1 in healthy and critically ill dogs. Vet Clin Pathol 2010; 39: 302–305. 30. Olsson M, Frankowiack M, Tengvall K et al. The dog as a genetic model for immunoglobulin A
XP725 Antibody List Lot 129K4830
722 Transportin 1 T0825 3842 TNPO1 M NP_002261.3 y y y 203 Cytokeratin peptide 4 C5176 3851 KRT4 M NP_002263.2 y n/d n/d 205 Cytokeratin peptide 7 C6417 3855 KRT7 M NP_005547.3 y n/d n/d 206 Cytokeratin
XP725 Antibody List Lot 129K4831
722 Transportin 1 T0825 3842 TNPO1 M NP_002261.3 y y y 203 Cytokeratin peptide 4 C5176 3851 KRT4 M NP_002263.2 y n/d n/d 205 Cytokeratin peptide 7 C6417 3855 KRT7 M NP_005547.3 y n/d n/d 206 Cytokeratin
XP725 Antibody List Lot 089K4791
722 Transportin 1 T0825 3842 TNPO1 M NP_002261.3 y y y 203 Cytokeratin peptide 4 C5176 3851 KRT4 M NP_002263.2 y n/d n/d 205 Cytokeratin peptide 7 C6417 3855 KRT7 M NP_005547.3 y n/d n/d 206 Cytokeratin
Stem Cell and Specialty Cell Culture Product Guide
645 070 225 644 BENL_Customer@millipore.com Czech Republic +420 (2) 205 138 41 +420 (2) 205 142 98 www.millipore.com or +420 (2) 205 138 42 Denmark (+45) 7010 5645 (+45) 7010 5644 denmark@millipore.com
MAPK: Antibodies, Proteins, Kits, siRNA and Reagents
Cancer. 4:937-947. Johnson, G. L. and Lapadat, R. 2002. Science. 298(5600): 1911-1912. Gaestel, M. and Shi, Y. 2002. Biol. Chem., Vol. 383: 1519-1536. Kolch, W. 2000. Biochem. J. 351:289-305.
List of Antibodies
M y n/d n/d 202 Cytohesin-1 C8979 M y n/d n/d 203 Cytokeratin peptide 4 C5176 M y n/d n/d 204 Cytokeratin CK5 C7785 M y n/d n/d 205 Cytokeratin peptide 7 C6417 M y n/d n/d 206 Cytokeratin 8.12 C7034 M y
XP725 Worksheet for Lot Number 071M4826
C2238 299 2 3 2 3 Cdc25c C0349 300 2 3 2 4 Cdc25c C0349 301 2 3 2 5 Cystatin B C9479 302 2 3 2 6 Cystatin B C9479 303 2 3 2 7 Cdc27 C7104 304 2 3 2 8 Cdc27 C7104 305 2
Cytoskeletal Signaling Antibodies, Reagents and Kits
WB Serum Rb IgG 100 µL 04-377 IC IH(P) anti-MEK2 (N-Terminus) H WB ELISA Pur M IgG 100 µg 04-305 Polyclonal Antibody Anti-phospho-MEK1 (Ser298) H M R WB APur Rb IgG 200 µL 07-339 Anti-phospho-MEK1
Halal Certificate
22SIJE82 303. 5-METHYL-2-HEPTEN-4-ONE, PREDOMINANTLY TRANS 98%, FG W376108 B49980 HC-22SIVT13 304. 5-Methyl-2-Phenyl-2-Hexenal W319912 B15662 HC-22SIZR79 305. 5-METHYL-2-PHENYL-2-HEXENAL 96%
Halal Certificate
23SI8H61 303. 5-METHYL-2-HEPTEN-4-ONE, PREDOMINANTLY TRANS 98%, FG W376108 B49980 HC-23SIPL91 304. 5-Methyl-2-Phenyl-2-Hexenal W319912 B15662 HC-23SIVD58 305. 5-METHYL-2-PHENYL-2-HEXENAL 96%
XP725 Antibody List
NP_059430.2 M y n/d n/d 203 Cytokeratin peptide 4 C5176 3851 KRT4 NP_002263.2 M y n/d n/d 204 Cytokeratin CK5 C7785 3875 KRT18 NP_954657.1 M y n/d n/d 205 Cytokeratin peptide 7 C6417 3855 KRT7 NP_005547.3
XP725 Antibody List 013M4793
NP_059430.2 M y n/d n/d 203 Cytokeratin peptide 4 C5176 3851 KRT4 NP_002263.2 M y n/d n/d 204 Cytokeratin CK5 C7785 3875 KRT18 NP_954657.1 M y n/d n/d 205 Cytokeratin peptide 7 C6417 3855 KRT7 NP_005547.3
Brochure: The Supelco® HPLC and UHPLC Column Selection Guide
endcapped 0 1 2 3 4 5 6 Intensity [x=107] 0 2 4 6 8 10 12 Time [min] EIC 209; 253; 507 – All MS EIC 197; 241; 483 – All